U.S. Food Stock News

Jacobs Solutions: recent returns and business mix Jacobs Solutions (J) has drawn investor attention after a period of mixed share performance, with short term returns soft yet longer multiyear figures remaining positive. This has prompted closer focus on how its global consulting and infrastructure operations stack up. See our latest analysis for Jacobs Solutions. At a share price of US$119.96, Jacobs Solutions has seen its short term momentum soften, with the share price return declining...

Investors may be wondering whether Rexford Industrial Realty is starting to look attractively priced, or if the current share price still leaves little room for upside. The stock closed at US$33.96 and has been under pressure recently, with the share price down 2.1% over the past week, 6.4% over the past month, 13.0% year to date and 2.8% over the last year. This extends a 25.2% decline over three years and 33.0% over five years. Recent coverage has focused on how industrial real estate...

Why the BoxX-NoAF trial update matters for AtriCure stock AtriCure (ATRC) has drawn fresh attention after announcing that its pivotal BoxX-NoAF clinical trial will complete patient enrollment 12 months earlier than planned, raising questions about what earlier data could mean for the stock. See our latest analysis for AtriCure. The BoxX-NoAF update has arrived at a time when AtriCure’s share price has fallen 31.46% year to date and its 1 year total shareholder return is down 21.26%, pointing...

Grand Canyon Education recently disclosed that it is in discussions with Grand Canyon University to amend their Master Services Agreement, potentially extending the partnership by eight years and revising how service fees are calculated. This contract review matters because it could reshape Grand Canyon Education’s revenue mix, concentration risk, and long-term reliance on its largest university partner. We’ll now examine how the potential eight-year extension of the Grand Canyon University...

In May 2026, Tandem Diabetes Care filed a US$47.40 million shelf registration for 3,260,000 common shares linked to its employee stock ownership plan and separately secured CE mark approval in Europe to extend use of its t:slim X2 and Tandem Mobi automated insulin delivery systems to pregnancy in type 1 diabetes and adults with type 2 diabetes. This broader European certification opens access to new patient groups and care settings, potentially reinforcing Tandem’s role within integrated...

MongoDB (MDB) recently reported first quarter results and raised its full year 2027 revenue and earnings guidance, even as higher for longer interest rate expectations pressured growth stocks in broader trading. See our latest analysis for MongoDB. MongoDB's share price has been volatile recently, with a 7 day share price return down 12.71%, yet a 30 day share price return of 17.73% and a 90 day share price return of 30.31% hinting at rebuilding momentum despite a year to date share price...

Recent share performance and business scale Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) has seen its stock decline 14.7% year to date, while the past 3 months show a gain of 4.4% and the month is broadly flat. For context on the underlying business, the company reports revenue of roughly $850,476.19 and net income of about $36,113.48. Its operations span cement, concrete, aggregates, railway services and other related activities in Argentina. See our latest analysis for...

Why Hotel101 Global Holdings Stock Is Drawing Attention Now Hotel101 Global Holdings (NasdaqCM:HBNB) has been drawing attention after a period of weak share performance, with the stock down 8% over the past month and 33% over the past 3 months. For investors, the recent slide sits alongside a market value of about US$1.32b, revenue of US$75.87 million from property development, and a net loss of US$26.71 million. This combination is prompting a closer look at the business model. See our...

Alamo Group (ALG) has refreshed its funding setup with a Fourth Amended and Restated Credit Agreement, giving the company access to up to US$602.5m in term and revolving borrowings through 2031. See our latest analysis for Alamo Group. Despite this refreshed credit capacity, Alamo Group's recent share price return has been weak, with the stock down 11.6% year to date and the 1 year total shareholder return declining 27.5%. This indicates that momentum has faded even as financing flexibility...

Yesway (YSWY) is drawing attention after its recent share performance, with the stock down about 15% over the past month following a modest single-day and past-week decline. See our latest analysis for Yesway. That 14.6% decline in the 30 day share price return, alongside a small year to date share price gain of 3.7% with the stock now at US$22.01, suggests recent momentum has cooled after a firmer start to the year. If you are looking beyond Yesway and want ideas with a similar risk on...

ArcBest (ARCB) is catching investor attention after a strong run in the stock, with returns of 37.4% over the past month and 77.5% over the past 3 months, prompting closer scrutiny of fundamentals. See our latest analysis for ArcBest. At a share price of US$166.22, ArcBest’s recent gains have been rapid, with strong short term share price returns building on already solid multi year total shareholder returns. This may indicate shifting expectations around its growth prospects and risk...

JFrog (FROG) is back in focus after robust Q1 results, fresh AI focused product launches, and news of its upcoming addition to the Russell 3000 Index, all drawing renewed investor attention. See our latest analysis for JFrog. After a sharp re-rating on strong Q1 results, fresh AI offerings and index inclusion news, JFrog’s share price has a 1 month return of 21.43% and a 1 year total shareholder return of 101.86%. The 3 year total shareholder return of 230.52% points to momentum that has...

Celcuity (CELC) has moved into focus after reporting Phase 3 VIKTORIA-1 data for gedatolisib and securing FDA Priority Review, alongside a newly priced US$500 million convertible senior notes offering due 2032. See our latest analysis for Celcuity. Despite the positive Phase 3 VIKTORIA-1 data and FDA Priority Review, Celcuity’s share price has pulled back sharply in recent weeks, with a 30 day share price return of down 33.3%, even as the 1 year total shareholder return is very large and...

Digital Turbine (APPS) has moved back into growth mode, with 15% year-over-year revenue expansion, sharply reduced net losses, and fresh guidance for fiscal 2027. These developments are supported by the launch of its new Launchpad platform. See our latest analysis for Digital Turbine. Those product launches and improving results have gone hand in hand with a sharp re-rating in the stock, with a 131.44% 1 month share price return and 82.97% 1 year total shareholder return. However, the 5 year...

Biohaven (BHVN) is back on investors’ radar after the company reported fresh R&D milestones, including first in human dosing of its PKM2 modulator BHV-8100 and early clinical data for degrader candidates BHV-1300 and BHV-1400. See our latest analysis for Biohaven. Biohaven’s recent R&D updates around BHV-8100, BHV-1300, and BHV-1400 appear to be the key backdrop to a choppy share price pattern, with a 30 day share price return of 12.78% but a 1 year total shareholder return that has declined...

In late May 2026, Pool Corporation announced a series of June conference presentations across Boston, New York, Chicago, and an Oppenheimer-hosted event, giving management multiple platforms to discuss its operations and outlook with investors. A recent Argosy Investors letter added further attention by highlighting Pool’s estimated 35–40% US swimming pool supply distribution market share and branch density, while also flagging macro and competitive risks. We’ll now examine how heightened...

Evertec recently disclosed that it had detected potential unauthorized access to customer data via a third-party support platform used by financial institution clients, primarily in Puerto Rico, and has begun investigation and containment efforts without reporting any service interruptions. This incident highlights how operational reliance on external technology vendors can introduce data security vulnerabilities that matter for both customers and investors. We’ll now examine how this...

Jackson Financial Inc. recently completed a US$748.73 million fixed-rate senior unsecured notes offering, issuing 6.150% callable notes due January 15, 2037 at a slight discount to par. At the same time, Jackson’s launch of new registered index-linked annuities with added index options and funding flexibility highlights an effort to broaden and modernize its retirement income lineup. Next, we’ll examine how this combination of new RILA features and fresh long-term funding could shape Jackson...

Bentley Systems recently reported a strong start to 2026, with revenue up 14.5% year over year and continued growth in subscription and annual recurring revenue, while reshaping its balance sheet by repaying convertible notes and securing a new US$550 million term loan. The combination of accelerating AI-enabled engineering workflows and fresh financing capacity for potential acquisitions and capital allocation is reshaping how Bentley Systems is positioned for future corporate decisions and...

Encompass Health recently completed a US$500,000,000 private offering of 5.875% senior notes due 2034, primarily to refinance existing 4.500% 2028 notes, repay revolving credit facility borrowings, and cover related fees, while also opening plans for a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia to replace a closed 19-bed unit. This combination of balance sheet reshaping through longer-dated, higher-coupon unsecured debt and continued investment in specialized...

In its latest quarterly update, Fidelity National Financial reported US$3.23 billion in revenue, an 18.2% year-on-year increase that nonetheless fell short of analyst expectations for both sales and earnings per share. This combination of growth and an earnings miss highlighted a gap between the company’s recent operating performance and the projections embedded in prior analyst models. Now we will consider how this revenue and EPS shortfall against expectations affects Fidelity National...

Recent commentary around ManpowerGroup (MAN) centers on a mixed picture, with its employment survey pointing to resilient hiring plans, while flat sales, declining earnings per share, and shrinking returns on capital keep investor sentiment cautious. See our latest analysis for ManpowerGroup. At a share price of US$32.43, ManpowerGroup has seen a 16.9% 90 day share price return and an 8.7% 30 day share price return, yet its 1 year total shareholder return is still down 16.5%. This suggests...

Warby Parker (NYSE:WRBY) has been added to the S&P SmallCap 600 index, a move that can influence its visibility with index funds and institutional investors. The company also announced a partnership with Google to develop AI-powered intelligent eyewear, bringing smart functionality to its consumer eyewear offering. Warby Parker operates across omnichannel retail and e-commerce, selling prescription glasses, sunglasses, contacts and related eye care services. The S&P SmallCap 600 addition...

BioMarin Pharmaceutical recently reported positive Phase 3 results for VOXZOGO in children with hypochondroplasia and advanced multiple regulatory filings and approvals, while integrating Amicus Therapeutics’ rare-disease drugs GALAFOLD and POMBILITI + OPFOLDA into its portfolio. This combination of pipeline progress and portfolio expansion underscores how BioMarin is deepening its focus on genetically driven rare skeletal and metabolic disorders. We’ll now examine how VOXZOGO’s progress in...